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Keywords: mandatory quality assurance benchmark RAM routine data documentation a b s t r a c t Purpose: This paper describes the development of quality indicators for an external statutory and crosssectoral quality assurance (QA) procedure in the context of the German health care system for adult patients suffering from schizophrenia, schizotypal and delusional disorders (F20-F29). Methods: Indicators were developed by a modified RAND/UCLA Appropriateness Method with 1) the compilation of an indicator register based on a systematic literature search and analyses of health care claims data, 2) the selection of indicators by an expert panel that rated them for relevance and for feasibility regarding implementation. Indicators rated positive for both relevance and feasibility formed the final indicator set. Results: 847 indicators were identified by different searches. Out of these, 56 were selected for the indicator register. During the formal consensus process the expert panel recommended another 45 indicators so that a total of 101 indicators needed to be considered by the panel. Of these, 27 indicators rated both relevant and feasible were included in the final set of indicators: this set included 4 indicators addressing structures, 19 indicators addressing processes and 4 indicators addressing outcomes. 17 indicators of the set will be reported by hospitals and 8 by psychiatric outpatient facilities. Two indicators considered to be cross-sectoral will be reported by both sectors. Discussion: F20-F29 and its treatment show some specific features which so far have not been addressed by any procedure within the statutory QA program of the German health care system. These features include: Schizophrenia and related disorders a) are potentially chronic conditions, b) are mainly treated in outpatient settings, c) require a multi-professional treatment approach and d) are treated regionally in catchment areas. These specific features in combination with the peculiarities of some legal, political and organizational characteristics of the German health care system and its statutory QA program have strongly influenced the development of indicators. The result was a seemingly ''imbalanced'' set of indicators with a greater number of indicators for inpatient than for outpatient care despite the fact that clinical reality is otherwise.
Introduction
Mental health care is a clinical area of interest in many international quality assurance (QA) programs that assess quality of care routinely [1] [2] [3] [4] [5] [6] [7] [8] . Additionally, there are many QA initiatives that include indicators for QA in mental health care both internationally and nationally in Germany [8, [32] [33] [34] [35] [36] . Until 2012, however, mental health care was not considered in statutory QA in Germany. In 2012, the Federal Joint Committee (FJC), the highest decisionmaking body of the joint self-government of physicians, hospitals, dentists and health insurance funds in Germany, commissioned the AQUA Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute) to develop a conceptual framework for an external statutory QA procedure in mental health care. Within this framework options for a QA procedure regarding patient population, service providers and assessment instruments were to be suggested by the AQUA Institute. Based on this concept, the FJC commissioned the development of a QA procedure for patients with schizophrenia, schizotypal and delusional disorders (F20-F29) in June 2014.
The present paper describes the development of this QA procedure. It thereby aims at highlighting and discussing the specific challenges of developing a cross-sectoral QA procedure in the context of the German health care system.
Background
External statutory QA in Germany strongly relies on the specific characteristics of the German health care system. To better understand why certain methods were used and specific outcomes achieved in the development of this cross-sectoral QA, it is important to highlight some features of the German health care system first [37] .
Since 2001 all German hospitals have been legally required to report data on special clinical areas for nationwide comparative quality measurement. Even though in 2007 the FJC decided to expand QA cross-sectorally and include health care provided in outpatient care [38] , until now, QA focuses on the inpatient sector. Cross-sectoral QA aims at making performance of health care providers in inpatient and outpatient care comparable, following
